Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ABOS Acumen Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.65 +3.1% | $15.06 -2.0% |
| StockIQ Score | 50C- Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 43D | 13F |
| Fundamental | 50C- | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 55C | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Acumen Pharmaceuticals (ABOS) outperforms Ascentage Pharma (AAPG) in most categories. Its technical score (82 vs. 18) and investor score (58 vs. 37) are significantly higher, showing stronger market trends and investor confidence. AAPG has a slightly better growth score (50 vs. 38), but ABOS has a more balanced fundamental and valuation score (both 50 vs. 35 and 38). ABOS also carries a "Moderate" rating, while AAPG is rated "Weak."